Cellectis (CLLS) Other Non Operating Income (2021 - 2025)
Cellectis (CLLS) posted Other Non Operating Income of -$283000.0 for Q3 2025, down 198.61% on a QoQ basis from $287000.0 in Q2 2025, and up 94.85% year-over-year from -$145236.5 in Q3 2024.
Cellectis (CLLS) has 5 years of Other Non Operating Income data on file, last reported at -$283000.0 in Q3 2025.
- In Q3 2025, Other Non Operating Income rose 94.85% year-over-year to -$283000.0; the TTM figure through Sep 2025 stood at -$4.7 million (down 1240.87% YoY), while the FY2021 annual figure was $1.8 million, changed N/A from the prior year.
- Other Non Operating Income eased to -$283000.0 in Q3 2025, from $287000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $12.9 million in Q3 2021 and bottomed at -$15.0 million in Q2 2021.
- A 5-year average of -$92933.3 and a median of $95000.0 in 2023 frame the typical range for Other Non Operating Income.
- The widest YoY moves for Other Non Operating Income: up 6110.53% in 2024, down 3495.06% in 2024.
- Year by year, Other Non Operating Income stood at $12.9 million in 2021, then tumbled by 168.91% to -$8.9 million in 2022, then jumped by 101.82% to $162000.0 in 2023, then sank by 3495.06% to -$5.5 million in 2024, then jumped by 94.85% to -$283000.0 in 2025.
- The last three Other Non Operating Income figures came in at -$283000.0 (Q3 2025), $287000.0 (Q2 2025), and $750000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 26.28 Mn |
| Jun 30, 2025 | -26.28 Mn |
| Mar 31, 2025 | 750,000.00 |
| Sep 30, 2024 | -5.50 Mn |
| Jun 30, 2024 | 5.90 Mn |
| Mar 31, 2024 | -146,000.00 |
| Sep 30, 2023 | 162,000.00 |
| Jun 30, 2023 | 95,000.00 |
| Mar 31, 2023 | -80,000.00 |
| Sep 30, 2022 | -8.90 Mn |
| Jun 30, 2022 | 8.44 Mn |
| Mar 31, 2022 | -126,000.00 |
| Sep 30, 2021 | 12.92 Mn |
| Jun 30, 2021 | -15.05 Mn |
| Mar 31, 2021 | 141,000.00 |